Applied Therapeutics APLT 深 滬
已收盤 08-15 16:00:00 美东时间
0.4791
+0.007
+1.50%
華盛通- 最 高0.4791
- 今 開0.4351
- 成交量 73.97万股
- 最 低 0.4351
- 昨 收 0.472
- 總市值 6803.22万
- 52周最高 10.6237
- 市盈率 靜 --
- 換手率 0.52%
- 52周最低 0.295
- 委 比 -52.68%
- 總股本 1.42亿
- 歷史最高 57.39
- 量 比 1.02
- 振 幅 9.32%
- 歷史最低 0.295
- 每 手 1
- 風險率 3.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Applied Therapeutics GAAP EPS of -$0.15 beats by $0.01
Applied Therapeutics press release (NASDAQ:APLT): Q2 GAAP EPS of -$0.15 beats by $0.01. Cash and cash equivalents totaled $30.4 million as of June 30, 2025, compared with $79.4 million at December 31,...
08-14 15:38
Applied Therapeutics Advances Pipeline Amid Financial Challenges
Applied Therapeutics ( ($APLT) ) has released its Q2 earnings. Here is a breakd...
08-14 12:30
Applied Therapeutics Q2 EPS $(0.15) Beats $(0.16) Estimate
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 5.06 percent. This is a 15.38 percent decrease over losses of $(0.13) per share
08-14 05:12
Applied Therapeutics Reports Second Quarter 2025 Financial Results
Applied Therapeutics reported Q2 2025 financial results with $30.4M in cash and a net loss of $21.3M. Key highlights include scheduling an FDA meeting for govorestat's NDA submission for CMT-SORD, presenting positive 12-month clinical results, launching a sponsored sorbitol assay, and entering an out-licensing agreement for AT-001. The company also advanced govorestat development for Classic Galactosemia and PMM2-CDG.
08-13 21:11
Altisource Portfolio Solutions S.A. Schedules Second Quarter 2025 Conference Call
Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) will report second-quarter 2025 earnings on July 24, 2025. A press release and presentation will be available on their Investor Relations website. The company will host a conference call at 8:30 a.m. EDT, with a live audio webcast accessible via the website. Participants should register and download necessary software in advance. A replay will be available approximately two hours after the call a...
07-21 16:45
Applied Therapeutics Announces Key Leadership Appointments
Applied Therapeutics Inc. announced the promotion of Evan Bailey, MD, to Chief Medical Officer, and Dottie Caplan to Executive Vice President, Patient Advocacy and Government Affairs. Bailey, previously Senior Vice President of Clinical Development, succeeds Riccardo Perfetti, MD, PhD, who served as CMO since 2018. Caplan, previously Senior Vice President of Patient Advocacy and Engagement, will now lead the company's advocacy and government affa...
06-17 20:05
RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target
RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Sector Perform and maintains $1.5 price target.
05-14 23:12
Applied Therapeutics Q1 EPS $(0.15) Beats $(0.19) Estimate
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.19) by 21.05 percent. This is a 6.25 percent increase over losses of $(0.16) per share
05-14 05:05
Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Applied Therapeutics (APLT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
04-17 17:30
